Hudson Bay Capital Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-129,398
| Closed | -$16.6M | – | 1271 |
|
|
2025
Q2 | $16.6M | Buy |
+129,398
| New | +$13.4M | 0.06% | 247 |
|
|
2024
Q2 | – | Sell |
-49,800
| Closed | -$4.72M | – | 787 |
|
|
2024
Q1 | $4.72M | Buy |
49,800
+9,800
| +25% | +$840K | 0.03% | 305 |
|
|
2023
Q4 | $3.69M | Sell |
40,000
-180,000
| -82% | -$11.7M | 0.02% | 357 |
|
|
2023
Q3 | $11M | Buy |
220,000
+73,400
| +50% | +$3.92M | 0.09% | 149 |
|
|
2023
Q2 | $9.27M | Sell |
146,600
-176,400
| -55% | -$9.59M | 0.07% | 185 |
|
|
2023
Q1 | $14.5M | Buy |
323,000
+109,832
| +52% | +$4.95M | 0.12% | 128 |
|
|
2022
Q4 | $9.34M | Buy |
213,168
+178,168
| +509% | +$8.54M | 0.1% | 186 |
|
|
2022
Q3 | $2.31M | Sell |
35,000
-200,900
| -85% | -$12.9M | 0.02% | 697 |
|
|
2022
Q2 | $11.9M | Buy |
235,900
+170,900
| +263% | +$10M | 0.09% | 149 |
|
|
2022
Q1 | $4.15M | Buy |
+65,000
| New | +$4.67M | 0.06% | 435 |
|
|
2021
Q4 | – | Sell |
-12,500
| Closed | -$1.28M | – | 1096 |
|
|
2021
Q3 | $1.28M | Sell |
12,500
-12,500
| -50% | -$1.16M | 0.02% | 705 |
|
|
2021
Q2 | $2.2M | Buy |
+25,000
| New | +$2.29M | 0.03% | 594 |
|
|
2020
Q3 | – | Sell |
-60,000
| Closed | -$4.68M | – | 553 |
|
|
2020
Q2 | $4.68M | Sell |
60,000
-25,000
| -29% | -$1.69M | 0.08% | 206 |
|
|
2020
Q1 | $4.97M | Buy |
85,000
+30,000
| +55% | +$1.93M | 0.12% | 157 |
|
|
2019
Q4 | $4.41M | Buy |
+55,000
| New | +$4.12M | 0.1% | 190 |
|
|
2019
Q2 | – | Sell |
-20,000
| Closed | -$1.6M | – | 451 |
|
|
2019
Q1 | $1.6M | Sell |
20,000
-45,000
| -69% | -$3.33M | 0.02% | 501 |
|
|
2018
Q4 | $3.5M | Hold |
65,000
| – | – | 0.05% | 381 |
|
|
2018
Q3 | $5.07M | Sell |
65,000
-10,000
| -13% | -$695K | 0.06% | 286 |
|
|
2018
Q2 | $4.76M | Buy |
75,000
+45,000
| +150% | +$3.58M | 0.07% | 296 |
|
|
2018
Q1 | $2.75M | Hold |
30,000
| – | – | 0.06% | 375 |
|
|
2017
Q4 | $2.26M | Buy |
+30,000
| New | +$2.11M | 0.05% | 296 |
|
Other funds holding BPMC
IA
HNB
Hudson Bay Capital Management's BPMC Position: Q3 2025 in Review
Hudson Bay Capital Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 129,398 shares — an estimated $16.6M sold.
Hudson Bay Capital Management first reported a position in BPMC in Q4 2017 and held it in 21 quarters. The position peaked at $16.6M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Hudson Bay Capital Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Hudson Bay Capital Management sold 129,398 Blueprint Medicines shares in Q3 2025, an estimated $16.6M.
- Hudson Bay Capital Management first reported a position in Blueprint Medicines in Q4 2017 and held it in 21 quarters.
- Hudson Bay Capital Management's Blueprint Medicines position peaked at $16.6M in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Hudson Bay Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.